Harvard Bioscience (HBIO) Misses Q4 EPS by 1c

Harvard Bioscience (NASDAQ: HBIO) reported Q4 EPS of $0.04, $0.01 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $28.4 million versus the consensus estimate of $30.4 million.

For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Reading (RDI) Tops Q2 EPS by 4c